profit from every $100 of sales.
$0$100
BlackRock Health Sciences
$47.62-0.89% today
+17.9% in 1 year
1-year low $37.671-year high $48.05
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2025.
0%20% a year
You pay $8.00 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What BlackRock Health Sciences sold, what it kept, and what it did with the cash.
Sales went from -$26.0 million in 2022 to $77.5 million in 2025, with $77.0 million of profit last year.
SalesProfit
BlackRock Health Sciences handed back more cash to shareholders than it generated last year.
$41M
Free cash flow 2025$55M
Bought back its own shares$14M
Paid as dividends$41M
BlackRock Health Sciences vs. similar companies
BlackRock Health Sciences grows the fastest of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| BlackRock Health Sciences | 8.0× · Cheap | ||
 BlackRock | 33.8× · Expensive | ||
 Blackstone | 48.5× · Expensive | ||
 Investor | 8.5× · Cheap | ||
 Brookfield | 71.1× · Very expensive |
AI analysis
An AI analyst reads BlackRock Health Sciences's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -26 | 20 | 24 | 78 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| -26 | 20 | 23 | 77 | |
| -2.10 | 1.44 | 1.63 | – | |
| – | – | – | – | |
| – | – | – | – | |
| 101.9% | 98.1% | 97.4% | 99.3% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 606 | 596 | 550 | 570 |
| Cash | 0 | 0 | 0 | 0 |
| Total debt | 0 | 0 | 0 | – |
| Total liabilities | 6 | 8 | 4 | 2 |
| 600 | 588 | 546 | 568 | |
| 13 | 14 | 14 | – | |
| – | – | – | – | |
| -4.4% | 3.4% | 4.3% | 13.5% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -1 | 32 | 66 | 55 | |
| – | – | – | – | |
| -1 | 32 | 66 | 55 | |
| Dividends paid | 33 | 35 | 36 | 41 |
| 0 | 0 | 30 | 14 | |
| – | – | – | – |
Valuation
- 8.0×
- –
- –
- 0.9×
- 7.9×
- 11.3×
- –
- 8.9%
- 12.5%
- 8.1%
Profitability
- 89.3%
- 305.2%
- 99.3%
- 301.6%
- 14.3%
- 5.0%
- 14.3%
- 13.5%
- 14.3%
- –
Growth
- +94.9%
- –
- −106.6%
- +5.6%
- −41.7%
Financial health
- 0.0×
- 0.00
- 0.2%
- 3,838.2×
- –
- –
- 0.05
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 15%of 827
Top 17%of 876
Top 3%of 879
Top 33%of 926
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Dec 31, 2023 | 0.62 | – | – |
8.1%of the share price, paid each year
On $1,000 invested$81a year at today's yield, before tax
+5.6%2020 to 2025
Raised2 yearsin a row, in our data
Paid per share, each year
$6.50 in 2015 → $3.15 in 2025
How safe it looks
52.8% of its profit
Room to growStretchedMore than it earns: 74.4%
News
Opposition to data centers will drive up inflation, says BlackRock’s Larry FinkMarketWatch · Oct 21, 2026BlackRock Is Building a Bitcoin ETF for Investors Who Can't Stomach the SwingsYahoo Finance · Oct 20, 2026Here Are Tuesday’s Top Wall Street Analyst Research Calls: Akamai Technolgies, Apple, Blackrock, Ford Motor, Healthcare Realty Trust, Noble, Sunoco LP, Venture Global, Western Midstream Partners, Zoetis, and MoreYahoo Finance · Oct 20, 2026BlackRock’s Fink sees AI shortages, not a bubble, as the bigger threatSeeking Alpha · Oct 20, 2026What Does BlackRock (BLK) Joining A $500 Billion AI Funding Push Mean?Yahoo Finance · Oct 19, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
4/7Passes 4 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
59No pass
Benjamin Graham
72Pass
Philip Fisher
76Pass
Peter Lynch
100Pass
Joel Greenblatt
48No pass
Charlie Munger
66Pass
Terry Smith
55No pass
Questions about BlackRock Health Sciences
Is BlackRock Health Sciences a good stock to buy?
A strong, very profitable business, and the price looks low. 4 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the BlackRock Health Sciences AI analysis
What does BlackRock Health Sciences do?
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. It is in Asset Management.
Does BlackRock Health Sciences pay a dividend?
Yes. At today's price the dividend is 8.1% a year, about 53% of its yearly profit. In 2025 it paid out $40.6 million in dividends.
Is BlackRock Health Sciences stock halal?
Yes. BlackRock Health Sciences passes our halal screen: its business is permitted and its debt is 0.1% of its market value, under the 30% limit. How we check
How has BlackRock Health Sciences stock done over the past year?
Up 17.9% over the past twelve months, to $47.62. It traded between $37.67 and $48.05, close to its high.
Who are BlackRock Health Sciences's competitors?
The largest listed companies in the same industry are BlackRock, Blackstone, Investor and Brookfield. The peers table on this page compares their profit, growth and price with BlackRock Health Sciences's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.